EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitHistorischer Beitrag

From Hippocrates to Biologics, The Evolving History of Pericarditis: A Review

Astefanos Al-Dalakta, Chadi Tabaja iD, Mohammad Alqahtani iD, Tom Kai Ming Wang iD, Massimo Imazio iD, Paul C Cremer iD, Sushil Allen Luis iD, George Lazaros iD, Allan L Klein iD

Circulation · 2026

DOI: 10.1161/circulationaha.126.079230 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Circulation, 2026. Verfasst von Astefanos Al-Dalakta und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascula…. Hauptthemen laut MEDLINE: Pericarditis, Biological Products. Die Arbeit nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pericarditis remains a common and clinically relevant cardiovascular condition whose diagnosis and management have evolved substantially over time. Understanding this historical progression provides important context for contemporary practice and emerging therapeutic strategies. Early descriptions, dating back to Hippocrates, framed pericarditis as a clinical observation, with more precise diagnostic characterization emerging in the 19th century through the work of Laennec and later refined by clinicians such as Spodick and Hatle. Initial treatment approaches were largely symptomatic or surgical, including pericardiectomy for advanced constrictive disease. The mid-twentieth century marked a shift toward medical therapy with the introduction of nonsteroidal anti-inflammatory drugs and corticosteroids, which improved symptom control but were limited by high recurrence rates. The advent of echocardiography transformed pericardial disease evaluation by enabling noninvasive diagnosis, hemodynamic assessment, and safer pericardiocentesis. More recently, cardiac magnetic resonance imaging has further advanced care by allowing detailed tissue characterization and improved risk stratification. Randomized trials established colchicine as a cornerstone therapy for both acute and recurrent pericarditis. A major paradigm shift has occurred with the recognition of autoinflammatory mechanisms underlying recurrent disease and the introduction of targeted interleukin-1 inhibition, including anakinra and rilonacept, particularly for refractory cases. Together, these advances reflect a transition from empirical management toward mechanism-based, personalized care. Ongoing progress in imaging, biomarker integration, and targeted immunomodulation is expected to further refine diagnosis, treatment, and long-term outcomes for patients with pericardial disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PericarditisBiological ProductsHumansHistory, 20th CenturyHistory, 21st CenturyHistory, AncientHistory, 19th CenturyHistory, 18th CenturyHistory, MedievalHistory, 17th CenturyAnimalsAnti-Inflammatory Agents, Non-Steroidal

Stichwörter der Autor:innen

cardiac MRImultimodality imagingpericarditisrilonacept

Substanzen

Biological ProductsAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Center for Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular and Thorac…
  • Department of Medicine, University of Udine and Cardiothoracic Department, University Santa Maria della Misericordia, Italy (M.I.).
  • Feinberg School of Medicine, Northwestern University, Chicago, IL (P.C.C.).
  • Divisions of Radiology and Rheumatology, Northwestern Memorial Hospital, Chicago, IL (P.C.C.).
  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (S.A.L.).
  • First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, Greece (G.L.).

ORCID-Profile: Chadi Tabaja, Mohammad Alqahtani, Tom Kai Ming Wang, Massimo Imazio, Paul C Cremer, Sushil Allen Luis, George Lazaros, Allan L Klein

Zitieren

APA

Al-Dalakta, A., Tabaja, C., Alqahtani, M., Wang, T. K. M., Imazio, M., Cremer, P. C., Luis, S. A., Lazaros, G., & Klein, A. L. (2026). From Hippocrates to Biologics, The Evolving History of Pericarditis: A Review. Circulation. https://doi.org/10.1161/circulationaha.126.079230

Vancouver

Al-Dalakta A, Tabaja C, Alqahtani M, Wang TKM, Imazio M, Cremer PC, et al. From Hippocrates to Biologics, The Evolving History of Pericarditis: A Review. Circulation. 2026. doi:10.1161/circulationaha.126.079230

BibTeX
@article{AlDalakta2026,
  author = {Al-Dalakta, Astefanos and Tabaja, Chadi and Alqahtani, Mohammad and Wang, Tom Kai Ming and Imazio, Massimo and Cremer, Paul C and Luis, Sushil Allen and Lazaros, George and Klein, Allan L},
  title = {From Hippocrates to Biologics, The Evolving History of Pericarditis: A Review},
  journal = {Circulation},
  year = {2026},
  doi = {10.1161/circulationaha.126.079230}
}
Kostenlos starten →